All News

The court's decision makes it more likely that generic versions of medications will be made available before their patents expire and will likely lead to reduced drug costs for consumers.

New therapies advance the treatment of this hematologic cancer.

Consumer Watchdog's latest lawsuit questions the legality of another mandatory mail-order program for specialty pharmaceuticals.

A federal judge grudgingly accepted the Obama administration's proposal to make Plan B One-Step available without restrictions and urged it to do the same for all levonorgestrel-based emergency contraceptives.

The Supreme Court today ruled that because DNA is a "product of nature," it cannot be protected by a patent-but complementary DNA made synthetically in a lab would be eligible for patent protection.

The FDA today approved denosumab (Xgeva injection, for subcutaneous use) for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.

As the emphasis in health care shifts from treatment to prevention, pharmacists are perfectly positioned to help patients lead healthier lives and avoid costly chronic conditions.

There are a number of factors to take into account when responding to FDA enforcement actions.

A study published online in JAMA Psychiatry found that hospitalization for an infection or an autoimmune disease increased the risk of a subsequent mood disorder diagnosis.

At the Association for Health Insurance Plan's (AHIP) conference this Thursday, medical directors from Cardinal Health Specialty Solutions and Aetna will provide expert insight into how collaboration between payers and physicians can directly lead to better cancer care that is more effective and costs less.

June is Migraine and Headache Awareness Month, which makes it the perfect time to review the stages and treatments of this painful condition that affects some 36 million Americans.

At a town hall event at the ASHP Summer Meeting in Minneapolis, CEO Paul Abramowitz updated the membership on the movement to attain pharmacist provider status.

Survey results from Henry Ford Hospital in Detroit suggest that an inpatient pharmacist-directed anticoagulation service increases patient satisfaction and may boost Medicare reimbursement as well.

CVS Caremark announced today that it has been awarded Specialty Pharmacy accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.

Disabled patients covered by Medicare who reported non-adherence to prescribed medications due to cost were significantly more likely to visit emergency departments than beneficiaries who adhered to medications.

Putting your employees' needs before your own can be the secret to effective workplace management.

The risk of developing ovarian cancer was reduced by more than a fourth for women who had ever taken oral contraceptives and by more than half for those who had taken them for at least 10 years.

The new process takes into account the efficacy, risk, cost, and societal benefit of a given specialty drug in determining whether it should be added to the hospital's formulary.

As the number of medications prescribed to adults has increased, so has the number of children exposed to and poisoned by prescription medications, indicating a need for better counseling and improved drug packaging.

A pair of new studies investigates the link between hypomagnesemia and use of proton pump inhibitors, but many questions remain.

The Biotechnology Industry Organization (BIO) and Oregon Bioscience Association (Oregon Bio) commend Oregon Governor John Kitzhaber for signing legislation designed to address the regulatory issues related to the interchangeability of biological medicines.

A study suggests that serum glucose levels that are elevated but not high enough to diagnose diabetes may indicate an elevated risk for Alzheimer's disease.

Illinois is now the 13th state to avoid enacting legislation that would slow patient access to biosimilars, which are new, affordable versions of costly brand biologic medicines that treat cancer, immune disorders and other complex diseases.

A comprehensive review of otitis media in North America addresses how shifts in the organisms that most commonly cause the condition affect preferred treatments.

Prime Therapeutics, a leading pharmacy benefit manager, announced today that its specialty pharmacy, Prime Therapeutics Specialty Pharmacy, has received full accreditation from URAC.

A study finds that use of sulfonylureas in the period leading up to an acute coronary syndrome is not associated with increased risk of death or heart failure.